Skip to main content
Close
Home
Society of Hospital Medicine
Presented by Society of Hospital Medicine
Home
Twitter Facebook LinkedIn Instagram YouTube Hospital Medicine Exchange Email RSS Feed

Nancy A. Melville

News

Adhering to endocrine therapy is hard. What can be done?

Author:
Nancy A. Melville
Publish date: September 26, 2023

Given the array of potential obstacles to endocrine therapy adherence, improving long-term use may be equally complex.

  • Read More

News

Tirzepatide superior to semaglutide for A1c control, weight loss

Author:
Nancy A. Melville
Publish date: September 25, 2023

“Although the efficacy of the high tirzepatide dose might make it a favorable choice, its real-world application can be affected on an individual’...

  • Read More

News

Thyroid ablation safety addressed by expert consensus

Author:
Nancy A. Melville
Publish date: September 20, 2023

“Probably the greatest concern shared by the writing group on this statement was the potential for clinicians to start ablation practices without...

  • Read More

News

BCR is unreliable surrogate for overall survival in prostate cancer

Author:
Nancy A. Melville
Publish date: September 7, 2023

The correlation between BCR-free survival and overall survival ranged from low to moderate.

  • Read More

News

Financial toxicity screening can reduce cancer cost burdens

Author:
Nancy A. Melville
Publish date: August 31, 2023

About one in five cancer survivors report experiencing financial toxicity, but financial monitoring is not a routine part of clinical care.

  • Read More

News

Hemophilia: Concizumab lessens bleeding, could expand treatment options

Author:
Nancy A. Melville
Publish date: August 31, 2023

The subcutaneous drug concizumab could be an important first treatment for hemophilia B with inhibitors; FDA resubmission is planned.

  • Read More

News

Post-SCT, better survival in children with healthy gut diversity

Author:
Nancy A. Melville
Publish date: August 24, 2023

After donor stem cell transplants, children with lower gut microbiota diversity show poorer survival and more complications.

  • Read More

News

Can caffeine improve thyroid function?

Author:
Nancy A. Melville
Publish date: August 23, 2023

The authors speculate that caffeine could potentially affect thyroid activity by affecting pituitary function.

  • Read More

News

SCD: Survival disparities seen across insurance types

Author:
Nancy A. Melville
Publish date: August 21, 2023

Nationwide study on sickle cell disease shows life expectancy remains shortened in adulthood, though improved for child patients.

  • Read More

News

Postpartum depression risk increased among sexual minority women

Author:
Nancy A. Melville
Publish date: August 15, 2023

Women identifying as sexual minorities show increases in postpartum depression, yet rates of reporting sexual orientation are low.

  • Read More

News

Antibody shows promise in preventing GVHD

Author:
Nancy A. Melville
Publish date: August 8, 2023

In translational research that shows potential for humans, an antibody blockade of the Notch signaling pathway prevents graft-versus-host-disease...

  • Read More

News

Vegetarian diets can improve high-risk cardiovascular disease

Author:
Nancy A. Melville
Publish date: July 25, 2023

“This meta-analysis is the first that generates evidence from randomized controlled trials to assess the association of vegetarian diets with...

  • Read More

News

T3 in hypothyroidism gets extra recommendation: British medical groups

Author:
Nancy A. Melville
Publish date: July 24, 2023

The ongoing debate over the use of LT3/LT4 combination therapy has persisted for more than 2 decades.

  • Read More

News

New cancer survival calculator focuses on oral cancer

Author:
Nancy A. Melville
Publish date: July 24, 2023

The broader aim of developing the tool is for this new approach to be “applicable for developing future prognostic models of cancer and noncancer...

  • Read More

News

Quizartinib boosts AML survival, regardless of SCT

Author:
Nancy A. Melville
Publish date: July 18, 2023

The FLT-inhibitor drug shows survival benefits in patients with higher-risk FLT3 mutations, with or without prior stem cell transplant.

  • Read More

Pages

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • last »
An Official Publication of the Society of Hospital Medicine

Society of Hospital Medicine
Twitter Facebook LinkedIn Instagram YouTube Hospital Medicine Exchange Email RSS Feed

Copyright  © 2023 Frontline Medical Communications Inc., 283-299 Market Street, 2 Gateway Center, 4th Floor, Newark, NJ 07102. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

Menu Close